Sign in

CIK 0001782223 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Pyxis Oncology, Inc.

Sign in to watch
Ticker
PYXS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831160910
Phone
(617) 221-9059
Business address
321 HARRISON AVENUE, BOSTON, MA, 02118
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. EFFECT Other Notice of Effectiveness
  4. 425 Deal Prospectus/Communication re Business Combination
  5. 8-K Event Executive or director change
  6. 424B3 Offering Prospectus
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. S-4/A Deal Registration Statement - Business Combination
  9. 144 Insider Sale of Securities
  10. UPLOAD Other SEC-generated Letter
  11. 8-K Event Shareholder vote results
  12. 144 Insider Sale of Securities
  13. S-4 Deal Registration Statement - Business Combination
  14. 144 Insider Sale of Securities
  15. 425 Deal Prospectus/Communication re Business Combination
  16. 425 Deal Prospectus/Communication re Business Combination
  17. 425 Deal Prospectus/Communication re Business Combination
  18. 425 Deal Prospectus/Communication re Business Combination
  19. 8-K Event Regulation FD disclosure
  20. 425 Deal Prospectus/Communication re Business Combination

Page 11 of 18 · 357 filings